Mechanistic insights into the multitarget synergistic efficacy of farrerol and β-lactam antibiotics in combating methicillin-resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01551-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Hangqian Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, beta-Lactams. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA), a principal causative agent of infections worldwide, urgently requires innovative interventions to counter its increasing risk. The present study revealed the profound impact of farrerol (FA), a robust bioactive agent, on the virulence and resistance mechanisms of MRSA. Our in-depth investigation revealed that FA significantly mitigated the β-lactam resistance of MRSA USA300, an achievement attributed to its precise interference with the BlaZ and Pbp2a protein. Additionally, FA indirectly diminishes the oligomerization of PBP2a by disrupting pigment synthesis, further contributing to its efficacy. In addition, FA extends its functional footprint beyond resistance modulation, exhibiting substantial antivirulence efficacy through selective inhibition of the accessory gene regulator (Agr) system, thereby significantly curbing MRSA pathogenicity in A549 cell and murine models. This study comprehensively explored the multiple impacts of FA on MRSA, shedding light on its versatile role as a BlaZ suppressor, pigment synthesis regulator, and AgrA activity modulator. These intricate findings firmly position FA as a compelling therapeutic candidate for addressing MRSA infections in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science, Jilin University, Changchun, China.
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Ch…
- Clinical Medical College, Changchun University of Chinese Medicine, Changchun, China.
- College of Animal Medicine, Jilin Agricultural University, Changchun, China.
ORCID-Profile: Li Wang, Jiazhang Qiu, Dacheng Wang
Förderung
- National Key Research and Development Program of China (NKPs)
Zitieren
APA
Yu, H., Wang, L., Liu, X., Zheng, J., Xiang, H., Zheng, Y., Lv, D., Yang, J., Zhang, Y., Qiu, J., & Wang, D. (2025). Mechanistic insights into the multitarget synergistic efficacy of farrerol and β-lactam antibiotics in combating methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01551-24
Vancouver
Yu H, Wang L, Liu X, Zheng J, Xiang H, Zheng Y, et al. Mechanistic insights into the multitarget synergistic efficacy of farrerol and β-lactam antibiotics in combating methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01551-24
BibTeX
@article{Yu2025,
author = {Yu, Hangqian and Wang, Li and Liu, Xin and Zheng, Jianze and Xiang, Hua and Zheng, Yanyang and Lv, Dongmei and Yang, Jingjing and Zhang, Yuxin and Qiu, Jiazhang and Wang, Dacheng},
title = {Mechanistic insights into the multitarget synergistic efficacy of farrerol and β-lactam antibiotics in combating methicillin-resistant Staphylococcus aureus},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01551-24}
}
EUVIMED